Concepedia

Heleen Scheerens

HS

Statistics

Publications

32

Citations

6K

H-Index

25

Active since

1992

Affiliations

Gilead Sciences (United States)(Current)

Allergy Associates Research Center

Utrecht University

Baylor College of Medicine

Genentech

Heleen Scheerens is an author at Gilead Sciences (United States) specializing in pharmacology, immunology, and inflammation.

Publications per year

1992–2017

32

Publications

32

IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

David Yen, Jeanne Cheung, Heleen Scheerens et al. · Journal of Clinical Investigation · 2006 · 1.5K citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

Pharmacy, Immunology, Pharmacology +12

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 675 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 377 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Membrane-Bound TNF Supports Secondary Lymphoid Organ Structure but Is Subservient to Secreted TNF in Driving Autoimmune Inflammation

Sigrid R. Ruuls, Robert M. Hoek, Vu N. Ngo et al. · Immunity · 2001 · 249 citations

Life Sciences, Cell Biology, Immunology +15

1–5 of 32